Equity Research Medical Instruments & Supplies

Should You Buy Alcon Inc. Stock in 2026?

By CirclFi Research Team · · Updated · 2/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Alcon Inc. (ALC) registers a weak Quality of Company score of 2.7/10. At the current price of $72.23, our 13-model framework evaluates whether the stock's discount is sufficient to compensate for high fundamental risks.

The short answer: 1 of 2 CirclFi valuation models project upside for Alcon Inc. (ALC) at $72.23 — the models are evenly split, with a Quality Score of 2.7/10 and Value-Trap risk of 0/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • Models are split: 1 bullish vs 1 bearish
  • Quality Score: 2.7/10 — Very Weak — significant concerns
  • Value Trap Risk: 0/100 — Minimal — healthy fundamentals
  • Fair Value Range: $6.13 – $137.92 (2149% spread)

Bullish Models

1 / 2

Bearish Models

1 / 2

Quality Score

2.7 /10

Very Weak — significant concerns

Value Trap Risk

0 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

2 /13
Active Models

Avg. confidence: 29%

What Is the Investment Case for Alcon Inc. (ALC) in 2026?

What Is the Bull Case vs the Bear Case for Alcon Inc. (ALC)?

Bull case versus bear case for Alcon Inc. (ALC) at $72.23, derived from 2 active CirclFi valuation models on 2026-08-27.
Bull case — $137.92 target (+90.9%) Bear case — $6.13 target (-91.5%)
According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model targets a fair value of $137.92 (+90.9%), anchoring the bull case with a methodology that provides a differentiated analytical lens. According to the CirclFi Quality of Company (QOC) framework, Alcon Inc.'s score of 2.7/10 signals fundamental weaknesses that could undermine the investment thesis.
According to the CirclFi Deep Alpha Valuation Engine, the Markov DDM model sees the stock as overvalued with a fair value of $6.13 (-91.5%), suggesting that the market price embeds overly optimistic growth assumptions.
According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +182.5% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology.

How Does ALC Compare to Its Medical Instruments & Supplies Peers?

ZJYL Jin Medical Internat
2.9
NNNN Anbio Biotechnology
2.4
TUTH Standard Dental Labs
3.2
ISRG Intuitive Surgical,
9.4
UEEC United Health Produc
4.1
RMD ResMed Inc.
9.4
UTMD Utah Medical Product
8.2
OSUR OraSure Technologies
6.8

Valuation data pages: ZJYL · NNNN · TUTH · ISRG · UEEC · RMD · UTMD · OSUR · BNGO

See full Medical Instruments & Supplies rankings →

Which Other Stocks Score Like ALC on Quality?

Closest companies to ALC’s Quality of Company score of 2.7/10, across all industries.

Why Do CirclFi’s 2 Models Disagree on ALC?

Spread

2149%

Fair Value Range

$6.13 – $137.92

A 2149% spread signals high uncertainty. The investment outcome depends heavily on which scenario plays out.

Most Bullish

Regime Cross

$137.92 (+90.9%)

Most Bearish

Markov DDM

$6.13 (-91.5%)

What Are the Biggest Risks of Buying ALC Stock?

Weak Fundamentals

QOC 2.7/10 signals below-average quality.

Model Disagreement

2149% spread signals high variance in projections.

Macro/Sector Risk

Medical Instruments & Supplies headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View ALC Data Page →

So Is Alcon Inc. (ALC) Worth Buying in 2026?

Alcon Inc. at $72.23 is a genuine coin-flip in our framework. The 1–1 bull-bear split across 2 models, +182.5% model spread, and median fair value of $72.03 (-0.3% vs price) argue for a watchlist position rather than a high-conviction bet. Quality at 2.7/10 adds additional caution to the mix.

These are quantitative model outputs, not investment recommendations. Alcon Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About ALC Stock?

Should I buy ALC stock right now?

Based on CirclFi's multi-model analysis, 1 of 2 models see upside for ALC at $72.23. The models are divided, which means the investment case depends heavily on your assumptions about Alcon Inc.'s future. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Alcon Inc.?

Key risks include: a below-average Quality Score of 2.7/10, indicating fundamental weakness; limited model coverage (2/13 active), reducing analytical confidence; wide model disagreement (2149% spread), signaling high uncertainty; general market and sector-specific risks affecting Medical Instruments & Supplies companies. Always diversify and consult a financial advisor.

How does ALC compare to its competitors?

Among Medical Instruments & Supplies peers, ALC holds a Quality Score of 2.7/10. Comparable companies include ZJYL (QOC 2.9), NNNN (QOC 2.4), TUTH (QOC 3.2). The relative ranking helps investors identify whether ALC offers better fundamental quality than alternatives in the same sector.

Is ALC a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. ALC's Quality Score of 2.7/10 raises concerns about long-term viability without significant operational improvements. Check our full data page for all 13 model estimates.

What price should I buy ALC at?

CirclFi does not provide target buy prices or price alerts. However, our 2 active models produce fair value estimates ranging from $6.13 to $137.92. At $72.23, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for ALC.

View ALC Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →